To The Moon

$iQiyi Inc.(IQ)$ released 22Q4 and the whole year financial report, an unexpected profit and greaterly improving free cash flow should send it to another YTD high?Q4 Performance ReviewRevenue was 7.59 billion yuan, a year-on-year increase of 2.8%, higher than the market expectation of 7.50 billion yuan;Among them, member service revenue was 4.7 billion yuan, a year-on-year increase of 15%; Advertising revenue was 1.55 billion yuan, down 7% year-on-year, higher than the market expectation of 1.39 billion yuan;Non-GAAP comparable earnings before interest and tax is 978 million yuan, and the profit rate reaches 13%, which is higher than the market ex

Some small-cap stocks tend to fly under the radar, but they still can deliver returns that rival any

Phamacy stocks rose 1.29% among S&P 500 sectors on Monday, the third-highest gainer behind Systems Software (+1.82%) and Technology Hardware sectors (+1.44%).We have observed that several Healthcare stocks have been hitting new year highs recently: for example: $Amylyx Pharmaceuticals, Inc.(AMLX)$ , $Imara Inc.(IMRA)$ , $Vertex Pharmaceuticals(VRTX)$ , $Eli Lilly and(LLY)$ , $Merck(MRK)$On Monday, $(IMRA)$ was up 15%,

Credit Suisse Group AG’s new chief has asked investors for less than 100 days to deliver a new turna